Breast Cancer Diagnosis and HER2+ Versus Triple Negative Discrimination by Infrared Spectral Histopathology

Breast cancer is a heterogeneous disease comprising distinct molecular subtypes that require accurate diagnosis for effective treatment. Conventional diagnostic methods primarily rely on histologic evaluation, which limits access to molecular-level information. Here, we present a label-free strategy... View More